Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-4-25
pubmed:abstractText
The aim of the present study was to evaluate the contribution of MAOB, COMT, NAT2 and CYP2D6 gene polymorphisms to early onset Parkinson's disease (PD). The study enrolled 134 patients with Parkinson's disease (early onset-EOPD--67 patients, and late onset--LOPD--patients), and 66 healthy individuals. Polymerane chain reaction restriction fragment length polymorphism (PCR-RFLP) methods were used for genotyping. Univariate analysis revealed a significant two-fold higher EOPD risk among carriers of MAOB allele A or AA genotype. Multivariate analysis revealed that MAOB allele A was an independent factor predisposing to EOPD. It was shown that neither NAT2, CYP2D6 nor COMT genotype was associated with PD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1353-8020
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
224-9
pubmed:dateRevised
2010-9-8
pubmed:meshHeading
pubmed-meshheading:17270484-Adult, pubmed-meshheading:17270484-Aged, pubmed-meshheading:17270484-Aged, 80 and over, pubmed-meshheading:17270484-Alleles, pubmed-meshheading:17270484-Alzheimer Disease, pubmed-meshheading:17270484-Arylamine N-Acetyltransferase, pubmed-meshheading:17270484-Catechol O-Methyltransferase, pubmed-meshheading:17270484-Cytochrome P-450 CYP2D6, pubmed-meshheading:17270484-Female, pubmed-meshheading:17270484-Gene Frequency, pubmed-meshheading:17270484-Genetic Predisposition to Disease, pubmed-meshheading:17270484-Humans, pubmed-meshheading:17270484-Logistic Models, pubmed-meshheading:17270484-Male, pubmed-meshheading:17270484-Middle Aged, pubmed-meshheading:17270484-Monoamine Oxidase, pubmed-meshheading:17270484-Multivariate Analysis, pubmed-meshheading:17270484-Polymorphism, Genetic
pubmed:year
2007
pubmed:articleTitle
Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease.
pubmed:affiliation
Departments of Experimental and Clinical Pharmacology, Pomeranian Medical University, Szczecin, Poland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't